Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymoma: benign appearance, malignant potential.

Richard F Riedel1, William R Burfeind

  • 1DUMC 3305, Durham, North Carolina 27710, USA.

The Oncologist
|September 5, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Light at the End of the Tunnel! Effects of 405 nm Visible Light Disinfection on Surgical Site Infection: A Prospective Randomized Cohort Study.

Surgical infections·2026
Same author

Multi-Omic Landscape of Gastrointestinal Stromal Tumors in a Real-World Patient Cohort of 1,427 Cases.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

A plain language summary of the AMPECT study: nab-sirolimus for advanced malignant perivascular epithelioid cell tumors.

Future oncology (London, England)·2025
Same journal

Prevalence, treatment and survival of Malignant Peripheral Nerve Sheath Tumor in the Danish neurofibromatosis type 1 population.

The oncologist·2026
Same journal

Molecular Tumor Board-Guided Osimertinib Therapy in EGFR L858R/Q701L-Mutant Lung Adenocarcinoma Supported by Functional Validation.

The oncologist·2026
Same journal

Phase 2 Dose Expansion Trial of OBI-3424, a DNA-Alkylating Prodrug, in Patients with Advanced Solid Tumors Expressing AKR1C3.

The oncologist·2026
Same journal

Divergent Biology and Outcomes of Somatic Transformations in Germ Cell Tumors.

The oncologist·2026
Same journal

Modernizing Disease Assessment in Prostate Cancer Trials: The Prostate Cancer Working Group 4 Framework.

The oncologist·2026
Same journal

Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial.

The oncologist·2026
See all related articles

Thymoma, a rare tumor, can invade locally and metastasize. Treatment depends on stage, with surgery as the primary approach, and radiation for invasive cases, offering durable responses even in advanced disease.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Immunology

Background:

  • Thymoma is a rare neoplasm originating from thymic epithelial cells.
  • It typically exhibits indolent growth but possesses malignant potential, including local invasion and regional metastasis.
  • Paraneoplastic syndromes, both immune-mediated and non-immune-mediated, are frequently associated with thymoma.

Observation:

  • Patient outcomes are significantly influenced by the stage of the disease at diagnosis.
  • The ability to achieve a complete surgical resection is a critical factor in determining prognosis.
  • Two cases of thymoma are presented to illustrate clinical presentation and management.

Findings:

  • Surgery remains the cornerstone of thymoma treatment.
  • Adjuvant radiation therapy is recommended for patients with invasive thymoma.

Related Experiment Videos

  • Thymoma demonstrates sensitivity to chemotherapy and radiation, enabling durable responses in patients with incompletely resected or inoperable disease.

    • Implications:

    • Optimal management strategies are crucial for improving patient outcomes in thymoma.
    • Early diagnosis and complete surgical resection are key to successful treatment.
    • Multimodal treatment approaches, including surgery, radiation, and chemotherapy, are effective for advanced or unresectable thymoma.